Cargando…
A novel radiolytic rotenone derivative, rotenoisin A, displays potent anticarcinogenic activity in breast cancer cells
Chemotherapy for cancer treatment has therapeutic limitations, such as drug resistance, excessive toxic effects and undesirable adverse effects. Therefore, efforts to improve the safety and efficacy of chemotherapeutic agents are essential. Ionizing radiation can improve physiological and pharmacolo...
Autores principales: | Bak, Dong-ho, Kang, Seong Hee, Park, Chul-hong, Chung, Byung Yeoup, Bai, Hyoung-Woo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7948853/ https://www.ncbi.nlm.nih.gov/pubmed/33615367 http://dx.doi.org/10.1093/jrr/rrab005 |
Ejemplares similares
-
Novel Radiolytic Rotenone Derivative, Rotenoisin B with Potent Anti-Carcinogenic Activity in Hepatic Cancer Cells
por: Badaboina, Srilatha, et al.
Publicado: (2015) -
Uncertainty quantification of bioassay functions for the internal dosimetry of radioiodine
por: Kwon, Tae-Eun, et al.
Publicado: (2020) -
Inhibitory Effects of Thermolysis Transformation Products of Rotenone on Nitric Oxide Production
por: Jeong, Gyeong Han, et al.
Publicado: (2023) -
Interaction of curcumin with glioblastoma cells via high and low linear energy transfer radiation therapy inducing radiosensitization effects
por: Kim, Jeong-Yub, et al.
Publicado: (2022) -
Combining radiation with PI3K isoform-selective inhibitor administration increases radiosensitivity and suppresses tumor growth in non-small cell lung cancer
por: Seol, Mi Youn, et al.
Publicado: (2022)